<?xml version="1.0" encoding="UTF-8"?>
<p>The pharmacokinetics of remdesivir have been summarized in documentation published by the US Food and Drug Administration (FDA). The FDA has issued an emergency use authorization (EUA) to license the emergency use of the unapproved drug remdesivir for management of suspected or laboratory-confirmed SARS-CoV-2 infection in adults and pediatric patients hospitalized with severe disease.
 <xref rid="cit0015" ref-type="bibr">15</xref>
</p>
